Trial Details
Not RecruitingBasic Information
| Clinical ID | c2026 |
|---|---|
| Identifier | CTIS2024-514740-82-00 |
| Trial Title | Subcutaneous vedolizumab drug de-escalation in inflammatory bowel disease: a multicentre randomised controlled study - NL83430.172.01 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease MedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856 MedDRA version: 20.0Level: PTClassification code: 10009900Term: Colitis ulcerative Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Entyvio 108 mg solution for injection in pre-filled syringe, Product Code:PRD8036142, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: |
Participant Information
| Sponsor | Stichting Amsterdam UMC |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |